VSCL
Vadivarhe Speciality Chemicals financials
- Market cap
- ₹31 Cr
- Sector
- Chemicals
What Vadivarhe Speciality Chemicals Ltd does
Vadivarhe Speciality Chemicals Ltd (VSCL) manufactures organic and inorganic chemicals, bio-chemicals, bulk drugs, drug intermediates and Active Pharmaceutical Ingredients (APIs) through custom synthesis, from a WHO-GMP certified plant at Vadivarhe, near Nashik, Maharashtra. It supplies these speciality chemicals, APIs and intermediates to pharmaceutical formulation manufacturers and personal-care product makers. In FY25 it commenced commercial production of over 10 APIs, marking its entry into the pharmaceutical value chain alongside its existing speciality-chemicals business.
Segments
- Speciality Chemicals
- Active Pharmaceutical Ingredients (APIs)
- Intermediates & Personal Care Ingredients
- Manufacturing facilities
- 1 (Vadivarhe, Nashik, Maharashtra)
- APIs in commercial production
- 10+
- Certifications
- ISO 9001; WHO-GMP (manufacturing, marketing & supply of APIs and intermediates)
- Key clients
- 11 pharma/chem companies incl. GlaxoSmithKline Pharmaceuticals, USV, Mankind Pharma, Macleods, Hetero Labs, Micro Labs
- Product categories
- Speciality chemicals, APIs, drug intermediates, personal care ingredients
- Years in operation
- 16 (since incorporation in 2009)
Quarterly results
Q4 FY26: revenue up 10.6%, net profit down 42.0% against the same quarter last year.
| Line item | Q2 FY23 | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 22 | 14 | 26 | 14 −32% | 23 +5% | 17 +21% | 29 +11% |
| EBITDA | 2 | 2 | -1 | 5 | -2 −224% | -4 −357% | -2 −170% | 3 −38% |
| Net profit | 0 | 1 | -4 | 4 | -3 −2041% | -6 −708% | -4 −3% | 2 −42% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −30.3% 1Y
1Y: ₹29.85 on 5 Sept 2025 → ₹20.8. High ₹31.5 (6 Jul 2026), low ₹16.05 (29 Dec 2025).
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
| Reserves | ₹2 Cr | ₹-7 Cr | ₹-6 Cr | ₹-6 Cr | ₹-19 Cr | ₹-17 Cr |
| Borrowings | ₹23 Cr | ₹24 Cr | ₹27 Cr | ₹26 Cr | ₹31 Cr | ₹32 Cr |
| Other liabilities | ₹9 Cr | ₹12 Cr | ₹13 Cr | ₹9 Cr | ₹14 Cr | ₹11 Cr |
| Total liabilities | ₹47 Cr | ₹42 Cr | ₹46 Cr | ₹42 Cr | ₹39 Cr | ₹39 Cr |
| Fixed assets | ₹26 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹22 Cr | ₹21 Cr |
| Capital work in progress | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹21 Cr | ₹16 Cr | ₹22 Cr | ₹18 Cr | ₹17 Cr | ₹17 Cr |
| Total assets | ₹47 Cr | ₹42 Cr | ₹46 Cr | ₹42 Cr | ₹39 Cr | ₹39 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters added +4.90 pp while the public trimmed −4.90 pp. The shareholder count shrank 5% to 428.
- Promoters
- 71.7%
- Public
- 28.3%
Since Jun 2025
- Promoters +4.90 pp
- Public −4.90 pp
How it drifted, 12 quarters
Over this window promoters fell from 74.6% to 71.7% — −2.9 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 74.6%, Public 25.4%.Dec '23: Promoters 74.6%, Public 25.4%.Mar '24: Promoters 74.6%, Public 25.4%.Jun '24: Promoters 74.6%, Public 25.4%.Sep '24: Promoters 70.0%, Public 30.1%.Dec '24: Promoters 66.8%, Public 33.2%.Mar '25: Promoters 66.8%, Public 33.2%.Jun '25: Promoters 66.8%, Public 33.2%.Sep '25: Promoters 66.8%, Public 33.2%.Dec '25: Promoters 66.8%, Public 33.2%.Mar '26: Promoters 66.8%, Public 33.2%.Jun '26: Promoters 71.7%, Public 28.3%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Sunil Haripant Pophale +13.63 pp 21.46% held
The same filing shows 4 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Vadivarhe Speciality Chemicals Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Meena Sunil Pophale | 40.25% | −6.99 pp |
| Sunil Haripant Pophale | 21.46% | +13.63 pp |
| Aditi Sunil Pophale | 10.00% | −1.73 pp |
| Sanjaykumar Harikishan | 1.48% | −0.26 pp |
| Ramesh Damani | 1.26% | −0.22 pp |
| Sunita Ajay Ramnathkar | 0.02% | unchanged |
| Pophale International LLP | 0.00% | unchanged |
| Zenvision Pharma LLP | 0.00% | unchanged |
| Respect Labs LLP | 0.00% | unchanged |
| Starkut Media And Entertainment Private Limited | 0.00% | unchanged |
| Manasi Sunil Pophale | 0.00% | unchanged |
| Reelabs Private Limited | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Vadivarhe Speciality Chemicals Ltd
Guides on how to read this kind of business and the numbers that matter.